A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
The scientific community is facing a ‘pollution problem’ in academic publishing, and one that poses a serious threat to the “trustworthiness, utility, and value of science and medicine”, according to … Continue Reading Science and medicine have a ‘publication pollution’ problem, according to newly published commentary
Should peer reviewers receive training? Should there be accreditation? These topics and more were discussed at a recent BioMed Central roadshow in Sydney, Australia. One of the attendees, at this … Continue Reading Peer review: are early career researchers thrown in at the deep end?
How should scientists think about papers that have undergone what appears to be a cursory peer review? Perhaps the papers were reviewed in a day — or less — or … Continue Reading What to do when peer review feels inadequate?
BioMed Central the open access publisher Global Roadshow will be in London on Wednesday 20th May 2015. This FREE to attend one day event will take place at the Kingsway Hall Hotel giving delegates … Continue Reading BioMed Central roadshow in London: “Making open access work for you: publishing, peer review and innovation”
The Washington Post announced recently (Friday, March 27), that BioMed Central has retracted 43 scientific papers due to concerns about fake peer review. According to the article, this is evidently … Continue Reading Major publisher retracts 43 scientific papers amid wider fake peer-review scandal
A blog by Nature Publishing this week explores various journal comparison websites that have sprung up over the past few years. These journal-comparison tools allow authors to search or filter journals by … Continue Reading Can’t decide where to publish? Ever tried a journal comparison site?
A study published in JAMA Internal Medicine in February 2015 (which is unfortunately behind a pay wall) indicated that clinical trials on treatments for cardiovascular diseases that were registered were … Continue Reading Trial registration may be associated with reduced publication bias
The UK EQUATOR Network – who have brought us guidelines like CONSORT and PRISMA – are running a “Publication School” from the 6th to 10th of July in Oxford. The … Continue Reading New course from the EQUATOR group on “The secrets of success in writing, publishing, and disseminating research articles”
Professional medical writing support improves the quality of clinical trial reporting, according to a study presented at the 2015 European Meeting of ISMPP in January 2015. The research shows that … Continue Reading Professional medical writing support improves the quality of clinical trial reporting
The ISMPP annual meeting will be held in Arlington, USA on the 27-29th April. The meeting will provide attendees with the opportunity to choose from 8 parallel sessions and 9 … Continue Reading The 11th Annual Meeting of the International Society of Medical Publication Professionals (ISMPP) is fast approaching
A study was published in Trials earlier this year to investigate, amongst other things, the experiences of investigators in publishing their research. Through interviews, trialists reported that the impact factors … Continue Reading Trialists consider the prestige and impact factors of academic journals to be the most important criteria for selecting those to which they would submit manuscripts
This news service is provided by Aspire Scientific Ltd and is intended to provide a freely accessible, central online news resource for everyone interested in medical writing, the development of … Continue Reading
A study in PLoS One earlier this year found that a relatively high proportion of completed US-based clinical trials did not achieve timely transparency either through publication in peer-review journals … Continue Reading A significant proportion of clinical trials are not published in a timely fashion
According to a study published in the BMJ in March: “Much of the information collected in unsuccessful drug trials is inaccessible to the broader research and practice communities”. The BMJ … Continue Reading Unsuccessful drug trials are less likely to be published in peer reviewed journals
A study reported in the New England Journal of Medicine in March found that “despite ethical mandates, statutory obligations, and considerable societal pressure, most trials that were funded by the … Continue Reading Further improvements needed: reporting of results on ClinicalTrials.gov